{
    "id": 20012,
    "fullName": "PPM1D D314A",
    "impact": "missense",
    "proteinEffect": "loss of function",
    "geneVariantDescriptions": [
        {
            "description": "PPM1D D314A lies within the PPM-type phosphatase domain of the Ppm1d protein (UniProt.org). D314A results in a loss of the Ppm1d phosphatase activity in cell culture (PMID: 16311512).",
            "references": [
                {
                    "id": 4975,
                    "pubMedId": 16311512,
                    "title": "Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/16311512"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 8493,
        "geneSymbol": "PPM1D",
        "terms": [
            "PPM1D",
            "IDDGIP",
            "JDVS",
            "PP2C-DELTA",
            "WIP1"
        ]
    },
    "variant": "D314A",
    "createDate": "03/22/2016",
    "updateDate": "03/22/2016",
    "referenceTranscriptCoordinates": {
        "id": 98265,
        "transcript": "NM_003620",
        "gDna": "chr17:g.60648006A>C",
        "cDna": "c.941A>C",
        "protein": "p.D314A",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 20332,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, transformed cells expressing PPM1D D314A did not demonstrate sensitivity to FK866 treatment compared to cells harboring wild-type Ppm1d in culture (PMID: 31439867).",
            "molecularProfile": {
                "id": 20452,
                "profileName": "PPM1D D314A"
            },
            "therapy": {
                "id": 5662,
                "therapyName": "FK866",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "no benefit",
            "references": [
                {
                    "id": 17806,
                    "pubMedId": 31439867,
                    "title": "PPM1D mutations silence NAPRT gene\u00a0expression and confer NAMPT inhibitor sensitivity in glioma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31439867"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 5268,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, CCT007093 did not inhibit proliferation of medulloblastoma cell lines overexpressing PPM1D D314A (PMID: 22379189).",
            "molecularProfile": {
                "id": 20452,
                "profileName": "PPM1D D314A"
            },
            "therapy": {
                "id": 3740,
                "therapyName": "CCT007093",
                "synonyms": null
            },
            "indication": {
                "id": 3857,
                "name": "large cell medulloblastoma",
                "source": "DOID"
            },
            "responseType": "decreased response",
            "references": [
                {
                    "id": 4974,
                    "pubMedId": 22379189,
                    "title": "HDM2 promotes WIP1-mediated medulloblastoma growth.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22379189"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        },
        {
            "id": 5272,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, CCT007093 and Nutlin-3 combination treatment did not inhibit growth in medulloblastoma cell lines over expressing Ppm1d D314A in culture (PMID: 22379189).",
            "molecularProfile": {
                "id": 20452,
                "profileName": "PPM1D D314A"
            },
            "therapy": {
                "id": 3806,
                "therapyName": "CCT007093 + Nutlin-3",
                "synonyms": null
            },
            "indication": {
                "id": 50902,
                "name": "medulloblastoma",
                "source": "DOID"
            },
            "responseType": "decreased response",
            "references": [
                {
                    "id": 4974,
                    "pubMedId": 22379189,
                    "title": "HDM2 promotes WIP1-mediated medulloblastoma growth.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22379189"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        }
    ],
    "molecularProfiles": [
        {
            "id": 20452,
            "profileName": "PPM1D D314A",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 98265,
            "transcript": "NM_003620",
            "gDna": "chr17:g.60648006A>C",
            "cDna": "c.941A>C",
            "protein": "p.D314A",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}